Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76376 - 76400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	CEBPD	1052	upregulated	tamibarotene results in increased expression of CEBPD mRNA	8q11.21	A24376
Tamibarotene	Investigational	CEBPG	1054	downregulated	tamibarotene results in decreased expression of CEBPG mRNA	19q13.11	A24376
Tamibarotene	Investigational	CEP135	9662	downregulated	tamibarotene results in decreased expression of CEP135 mRNA	4q12	A24376
Tamibarotene	Investigational	CGB3	1082	downregulated	tamibarotene results in decreased expression of CGB3 mRNA	19q13.33	A24376
Tamibarotene	Investigational	CHKA	1119	downregulated	tamibarotene results in decreased expression of CHKA mRNA	11q13.2	A24376
Tamibarotene	Investigational	CIITA	4261	upregulated	tamibarotene results in increased expression of CIITA mRNA	16p13.13	A20516
Tamibarotene	Investigational	CLCNKA	1187	downregulated	tamibarotene results in decreased expression of CLCNKA mRNA	1p36.13	A24376
Tamibarotene	Investigational	CLTB	1212	upregulated	tamibarotene results in increased expression of CLTB mRNA	5q35.2	A24376
Tamibarotene	Investigational	CORO1A	11151	upregulated	tamibarotene results in increased expression of CORO1A mRNA	16p11.2	A24376
Tamibarotene	Investigational	CREB3	10488	upregulated	tamibarotene results in increased expression of CREB3 mRNA	9p13.3	A24376
Tamibarotene	Investigational	CREG1	8804	upregulated	tamibarotene results in increased expression of CREG1 mRNA	1q24.2	A24376
Tamibarotene	Investigational	CST3	1471	upregulated	tamibarotene results in increased expression of CST3 mRNA	20p11.21	A24376
Tamibarotene	Investigational	CTIF	9811	downregulated	tamibarotene results in decreased expression of CTIF mRNA	18q21.1	A24376
Tamibarotene	Investigational	CTNNAL1	8727	downregulated	tamibarotene results in decreased expression of CTNNAL1 mRNA	9q31.3	A24376
Tamibarotene	Investigational	CTSA	5476	upregulated	tamibarotene results in increased expression of CTSA mRNA	20q13.12	A20516
Tamibarotene	Investigational	CTSD	1509	upregulated	tamibarotene results in increased expression of CTSD mRNA	11p15.5	A24376
Tamibarotene	Investigational	CUL1	8454	downregulated	tamibarotene results in decreased expression of CUL1 mRNA	7q36.1	A24376
Tamibarotene	Investigational	CXCR5	643	upregulated	tamibarotene results in increased expression of CXCR5 mRNA	11q23.3	A24376
Tamibarotene	Investigational	CYBA	1535	upregulated	tamibarotene results in increased expression of CYBA mRNA	16q24.2	A24376
Tamibarotene	Investigational	CYBB	1536	upregulated	tamibarotene results in increased expression of CYBB mRNA	Xp21.1-p11.4	A24376
Tamibarotene	Investigational	DAAM1	23002	downregulated	tamibarotene results in decreased expression of DAAM1 mRNA	14q23.1	A24376
Tamibarotene	Investigational	DAPK2	23604	upregulated	tamibarotene results in increased expression of DAPK2 mRNA	15q22.31	A24376
Tamibarotene	Investigational	DDX21	9188	downregulated	tamibarotene results in decreased expression of DDX21 mRNA	10q22.1	A24376
Tamibarotene	Investigational	DHRS3	9249	upregulated	tamibarotene results in increased expression of DHRS3 mRNA	1p36.21	A24376
Tamibarotene	Investigational	DOK2	9046	upregulated	tamibarotene results in increased expression of DOK2 mRNA	8p21.3	A24376

Displaying entries 76376 - 76400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability